Mortality Caused by Candida auris Bloodstream Infections in Comparison with Other Candida Species, a Multicentre Retrospective Cohort

Candida auris is an emerging pathogen considered to be critical in the World Health Organization fungal organisms list. The study aims determine mortality and hospital stays attributed (C. auris) compared other species adult patients with candidemia. A retrospective cohort of adults candidemia was examined from seven centres Colombia between 2016 2021. primary outcome 30-day mortality, secondary length stay among survivors. Adjustment confounding variables performed using inverse probability weights exposure propensity score (candidemia by C. auris), survival regression models (Weibull distribution), a counting model (negative binomial distribution). value 244 (47.6%) 512 died within first 30 days. crude 38.1% vs. 51.1% non-auris (CNA). In Weibull model, group lower (adjusted HR: aHR- 0.69, 95% CI: 0.53–0.90). Antifungal treatment also decreased aHR 0.36 (95% CI 0.27–0.47), while presence septic shock on patient progression increased it, 1.73 1.41–2.13). Among who survived, no differences were observed CNA groups, incidence rate ratio 0.92 0.68–1.22). Mortality bloodstream infections appears when adjusted for numerous regarding progression. We identified significant effect surviving patients.